BREAKING NEWS
New Credit Card Rules from September, 2024: Updates on FDs, Aadhaar etc. New Credit Card Rules from September, 2024: Updates... After CCI, NCLT gives green light to Viacom 18-Star India INR 70,000 Cr Merger After CCI, NCLT gives green light to Viacom... Sovereign Gold Bonds Vs. Physical Gold: Which Is the Ultimate Investment Strategy for You? Sovereign Gold Bonds Vs. Physical Gold: Which Is... Simple Energy Secures USD 20 Million to Supercharge E-Scooter Production and Transform EV Market Simple Energy Secures USD 20 Million to Supercharge... The Power of Systematic Transfer Plans (STP) Over SIPs for Smarter Wealth Growth: Know How to Maximize Your Wealth The Power of Systematic Transfer Plans (STP) Over... ITC to Invest INR 20,000 Crore in India’s Growth: New Products, Market Expansion and Strategic Innovation ITC to Invest INR 20,000 Crore in India’s... ONDC Surpasses 5.7 Lakh Sellers: Rapid Growth and Expanding Digital Commerce Network in India ONDC Surpasses 5.7 Lakh Sellers: Rapid Growth and... 71% Intraday Traders Lose Money And 76% Under 30 Face High Loss Rates: Check What Else This New Study By SEBI Says For FY23 71% Intraday Traders Lose Money And 76% Under... Special Packages to Boost Bihar and Andhra Pradesh: Check How Budget 2024 is Strengthening its Key Allies Special Packages to Boost Bihar and Andhra Pradesh:... Union Budget 2024: An INR 1.52 Lakh Crore Boost for Agriculture and Sustainable Farming Practices Union Budget 2024: An INR 1.52 Lakh Crore...
Updated: July 8, 2024

‘Aditi’, an affordable health insurance by Narayan Health: Check how this can revolutionize insurance sector

Narayana Health introduces healthcare insurance, 'Aditi'. It is an INR 10,000 annual premium health insurance covering surgery up to INR 1 crore and treatments at INR 5 lakh. Their main challenges include hospital-centric care and potential overuse of surgeries. They are aiming to complement existing government schemes like Ayushmaan Bharat.

Read more
Updated: June 22, 2024

Sun Pharma’s Dadra Facility Receives USFDA Warning Letter for cGMP Violations: What Happens Next?

Sun Pharmaceuticals Limited received a USFDA warning letter for its Dadra facility. This was due to cGMP violations following an inspection in December 2023. Despite all the violations and issues Sun Pharma has implemented corrective measures. USFDA will release the letter's contents soon.

Read more
Updated: April 27, 2024

Zydus Lifesciences Receives FDA Approval for Tretinoin Cream

However, earlier this week, the company encountered regulatory challenges when its injectable manufacturing site in Jarod, near Vadodara, Gujarat, received 10 observations from the US health regulator post-inspection

Read more
Updated: April 13, 2024

Sun Pharma’s Dadra Facility Classified as Official Action Indicated by USFDA

Inspection of Dadra Facility by USFDA was initiated on 4th December 2023 and concluded on 15th December 2023. Following the news, Sun Pharma’s shares went down by 3% on the BSE

Read more
Updated: April 9, 2024

Aurobindo Pharma’s Injectable Facility Receives Observations from US FDA

While Aurobindo Pharma reassured stakeholders about its commitment towards compliance with the US FDA norms, the comments indicate areas that need attention to ensure adherence to the regulatory standards

Read more
Advertisement
Updated: March 18, 2024

HiLabs Secures USD 39 Million in Series B Financing for AI-Powered Healthcare Solutions

HiLabs journey started from Yale University in USA, with a modest team comprising interns and 2 full-time employees based in India, the startup has grown significantly

Read more
Advertisement
 Welcome to Your Ad
Welcome to Your Ad
 Welcome to Your Ad
Welcome to Your Ad
 Welcome to Your Ad
Welcome to Your Ad
 Welcome to Your Ad
Welcome to Your Ad
 Welcome to Your Ad
Welcome to Your Ad